Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Aehr Test Systems’s stock clocked out at $18.78, down -10.19% from its previous closing price of $20.91. In other words, the price has decreased by -$10.19 from its previous closing price. On the day, 1.7 million shares were traded. AEHR stock price reached its highest trading level at $21.3801 during the session, while it also had its lowest trading level at $18.615.
Ratios:
To gain a deeper understanding of AEHR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 5.68. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on July 17, 2024, Upgraded its rating to Buy and sets its target price to $25 from $12 previously.
On March 26, 2024, Craig Hallum Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 25 ’25 when OLIPHANT LAURA sold 5,000 shares for $21.50 per share. The transaction valued at 107,502 led to the insider holds 7,665 shares of the business.
OLIPHANT LAURA bought 5,000 shares of AEHR for $106,600 on Jul 25 ’25. On Jul 22 ’25, another insider, POSEDEL RHEA J, who serves as the Director of the company, sold 18,000 shares for $19.83 each. As a result, the insider received 356,972 and left with 71,163 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEHR now has a Market Capitalization of 561090112 and an Enterprise Value of 547391040. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.48 while its Price-to-Book (P/B) ratio in mrq is 4.57. Its current Enterprise Value per Revenue stands at 9.283 whereas that against EBITDA is -1192.573.
Stock Price History:
The Beta on a monthly basis for AEHR is 2.41, which has changed by -0.004769504 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, AEHR has reached a high of $23.00, while it has fallen to a 52-week low of $6.27. The 50-Day Moving Average of the stock is 43.11%, while the 200-Day Moving Average is calculated to be 58.86%.
Shares Statistics:
It appears that AEHR traded 1.23M shares on average per day over the past three months and 1961360 shares per day over the past ten days. A total of 29.88M shares are outstanding, with a floating share count of 27.61M. Insiders hold about 7.26% of the company’s shares, while institutions hold 65.44% stake in the company. Shares short for AEHR as of 1752537600 were 6583933 with a Short Ratio of 5.36, compared to 1749772800 on 6704496. Therefore, it implies a Short% of Shares Outstanding of 6583933 and a Short% of Float of 23.189999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Aehr Test Systems (AEHR) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.02, with high estimates of $0.04 and low estimates of $0.0.
Analysts are recommending an EPS of between $0.18 and $0.06 for the fiscal current year, implying an average EPS of $0.11. EPS for the following year is $0.32, with 3.0 analysts recommending between $0.46 and $0.15.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $11.46M. It ranges from a high estimate of $14.19M to a low estimate of $10.06M. As of the current estimate, Aehr Test Systems’s year-ago sales were $13.12MFor the next quarter, 3 analysts are estimating revenue of $14.4M. There is a high estimate of $17.21M for the next quarter, whereas the lowest estimate is $12.3M.
A total of 3 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $64.49M, while the lowest revenue estimate was $55.69M, resulting in an average revenue estimate of $61.36M. In the same quarter a year ago, actual revenue was $58.97MBased on 3 analysts’ estimates, the company’s revenue will be $81.92M in the next fiscal year. The high estimate is $89.13M and the low estimate is $74.82M.
